|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 127, Issue 9 1845-1855, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
DP Rice, T Aberg, Y Chan, Z Tang, PJ Kettunen, L Pakarinen, RE Maxson and I Thesleff
Institute of Biotechnology and Institute of Dentistry, PO Box 56, Finland. rice@operoni.helsinki.fi
Mutations in the FGFR1-FGFR3 and TWIST genes are known to cause craniosynostosis, the former by constitutive activation and the latter by haploinsufficiency. Although clinically achieving the same end result, the premature fusion of the calvarial bones, it is not known whether these genes lie in the same or independent pathways during calvarial bone development and later in suture closure. We have previously shown that Fgfr2c is expressed at the osteogenic fronts of the developing calvarial bones and that, when FGF is applied via beads to the osteogenic fronts, suture closure is accelerated (Kim, H.-J., Rice, D. P. C., Kettunen, P. J. and Thesleff, I. (1998) Development 125, 1241-1251). In order to investigate further the role of FGF signalling during mouse calvarial bone and suture development, we have performed detailed expression analysis of the splicing variants of Fgfr1-Fgfr3 and Fgfr4, as well as their potential ligand Fgf2. The IIIc splice variants of Fgfr1-Fgfr3 as well as the IIIb variant of Fgfr2 being expressed by differentiating osteoblasts at the osteogenic fronts (E15). In comparison to Fgf9, Fgf2 showed a more restricted expression pattern being primarily expressed in the sutural mesenchyme between the osteogenic fronts. We also carried out a detailed expression analysis of the helix-loop-helix factors (HLH) Twist and Id1 during calvaria and suture development (E10-P6). Twist and Id1 were expressed by early preosteoblasts, in patterns that overlapped those of the FGF ligands, but as these cells differentiated their expression dramatically decreased. Signalling pathways were further studied in vitro, in E15 mouse calvarial explants. Beads soaked in FGF2 induced Twist and inhibited Bsp, a marker of functioning osteoblasts. Meanwhile, BMP2 upregulated Id1. Id1 is a dominant negative HLH thought to inhibit basic HLH such as Twist. In Drosophila, the FGF receptor FR1 is known to be downstream of Twist. We demonstrated that in Twist(+/)(-) mice, FGFR2 protein expression was altered. We propose a model of osteoblast differentiation integrating Twist and FGF in the same pathway, in which FGF acts both at early and late stages. Disruption of this pathway may lead to craniosynostosis.
This article has been cited by other articles:
![]() |
M.-C. Ting, N. L. Wu, P. G. Roybal, J. Sun, L. Liu, Y. Yen, and R. E. Maxson Jr EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis Development, March 1, 2009; 136(5): 855 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moenning, R. Jager, A. Egert, W. Kress, E. Wardelmann, and H. Schorle Sustained Platelet-Derived Growth Factor Receptor {alpha} Signaling in Osteoblasts Results in Craniosynostosis by Overactivating the Phospholipase C-{gamma} Pathway Mol. Cell. Biol., February 1, 2009; 29(3): 881 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Yuen, W.-K. Kwok, K.-K. Chan, C.-W. Chua, Y.-P. Chan, Y.-Y. Chu, Y.-C. Wong, X. Wang, and K.-W. Chan TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction Carcinogenesis, August 1, 2008; 29(8): 1509 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
H K Datta, W F Ng, J A Walker, S P Tuck, and S S Varanasi The cell biology of bone metabolism J. Clin. Pathol., May 1, 2008; 61(5): 577 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Merrill, B. F. Eames, S. J. Weston, T. Heath, and R. A. Schneider Mesenchyme-dependent BMP signaling directs the timing of mandibular osteogenesis Development, April 1, 2008; 135(7): 1223 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Laursen, E. Mielke, P. Iannaccone, and E.-M. Fuchtbauer Mechanism of Transcriptional Activation by the Proto-oncogene Twist1 J. Biol. Chem., November 30, 2007; 282(48): 34623 - 34633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Gilbert, G. Bender, E. Betters, M. Yin, and J. A. Cebra-Thomas The contribution of neural crest cells to the nuchal bone and plastron of the turtle shell Integr. Comp. Biol., September 1, 2007; 47(3): 401 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bouvard, A. Aszodi, G. Kostka, M. R. Block, C. Albiges-Rizo, and R. Fassler Defective osteoblast function in ICAP-1-deficient mice Development, July 15, 2007; 134(14): 2615 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayashi, K. Nimura, K. Kashiwagi, T. Harada, K. Takaoka, H. Kato, K. Tamai, and Y. Kaneda Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling J. Cell Sci., April 15, 2007; 120(8): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Veltmaat, F. Relaix, L. T. Le, K. Kratochwil, F. G. Sala, W. van Veelen, R. Rice, B. Spencer-Dene, A. A. Mailleux, D. P. Rice, et al. Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes Development, June 15, 2006; 133(12): 2325 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Valta, T. Hentunen, Q. Qu, E. M. Valve, A. Harjula, J. A. Seppanen, H. K. Vaananen, and P. L. Harkonen Regulation of Osteoblast Differentiation: A Novel Function for Fibroblast Growth Factor 8 Endocrinology, May 1, 2006; 147(5): 2171 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaki, Y. Ito, P. Bringas Jr, S. Chou, M. M. Urata, H. Slavkin, and Y. Chai TGF{beta}-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development Development, January 15, 2006; 133(2): 371 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Deckelbaum, A. Majithia, T. Booker, J. E. Henderson, and C. A. Loomis The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling Development, January 1, 2006; 133(1): 63 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. Xiao, F. Yang, B. O. Karim, A. J. Iacovelli, J. Cai, C. P. Lerner, J. T. Richtsmeier, J. M. Leszl, C. A. Hill, et al. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+/S252W mouse Development, August 1, 2005; 132(15): 3537 - 3548. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guenou, K. Kaabeche, S. L. Mee, and P. J. Marie A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome Hum. Mol. Genet., June 1, 2005; 14(11): 1429 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aberg, R. Rice, D. Rice, I. Thesleff, and J. Waltimo-Siren Chondrogenic Potential of Mouse Calvarial Mesenchyme J. Histochem. Cytochem., May 1, 2005; 53(5): 653 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mansukhani, D. Ambrosetti, G. Holmes, L. Cornivelli, and C. Basilico Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation J. Cell Biol., March 28, 2005; 168(7): 1065 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanimoto, M. Yokozeki, K. Hiura, K. Matsumoto, H. Nakanishi, T. Matsumoto, P. J. Marie, and K. Moriyama A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome J. Biol. Chem., October 29, 2004; 279(44): 45926 - 45934. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hong and J.J. Mao Tissue-engineered Rabbit Cranial Suture from Autologous Fibroblasts and BMP2 Journal of Dental Research, October 1, 2004; 83(10): 751 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. F. Twigg, R. Kan, C. Babbs, E. G. Bochukova, S. P. Robertson, S. A. Wall, G. M. Morriss-Kay, and A. O. M. Wilkie Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome PNAS, June 8, 2004; 101(23): 8652 - 8657. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bertling, P. Hotulainen, P. K. Mattila, T. Matilainen, M. Salminen, and P. Lappalainen Cyclase-associated Protein 1 (CAP1) Promotes Cofilin-induced Actin Dynamics in Mammalian Nonmuscle Cells Mol. Biol. Cell, May 1, 2004; 15(5): 2324 - 2334. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valverde-Franco, H. Liu, D. Davidson, S. Chai, H. Valderrama-Carvajal, D. Goltzman, D. M. Ornitz, and J. E. Henderson Defective bone mineralization and osteopenia in young adult FGFR3-/- mice Hum. Mol. Genet., February 1, 2004; 13(3): 271 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Hajihosseini, M. D. Lalioti, S. Arthaud, H. R. Burgar, J. M. Brown, S. R. F. Twigg, A. O. M. Wilkie, and J. K. Heath Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics Development, January 15, 2004; 131(2): 325 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Ibrahimi, F. Zhang, A. V. Eliseenkova, R. J. Linhardt, and M. Mohammadi Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity Hum. Mol. Genet., January 1, 2004; 13(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishii, A. E. Merrill, Y.-S. Chan, I. Gitelman, D. P. C. Rice, H. M. Sucov, and R. E. Maxson Jr Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault Development, December 15, 2003; 130(24): 6131 - 6142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Vartiainen, E. M. Sarkkinen, T. Matilainen, M. Salminen, and P. Lappalainen Mammals Have Two Twinfilin Isoforms Whose Subcellular Localizations and Tissue Distributions Are Differentially Regulated J. Biol. Chem., September 5, 2003; 278(36): 34347 - 34355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Mattila, M. Salminen, T. Yamashiro, and P. Lappalainen Mouse MIM, a Tissue-specific Regulator of Cytoskeletal Dynamics, Interacts with ATP-Actin Monomers through Its C-terminal WH2 Domain J. Biol. Chem., February 28, 2003; 278(10): 8452 - 8459. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.J. Mao Mechanobiology of Craniofacial Sutures Journal of Dental Research, December 1, 2002; 81(12): 810 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xiao, D. Jiang, R. Gopalakrishnan, and R. T. Franceschi Fibroblast Growth Factor 2 Induction of the Osteocalcin Gene Requires MAPK Activity and Phosphorylation of the Osteoblast Transcription Factor, Cbfa1/Runx2 J. Biol. Chem., September 20, 2002; 277(39): 36181 - 36187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ornitz and P. J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes & Dev., June 15, 2002; 16(12): 1446 - 1465. [Full Text] [PDF] |
||||
![]() |
Z. Liu, J. Xu, J. S. Colvin, and D. M. Ornitz Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18 Genes & Dev., April 1, 2002; 16(7): 859 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ohbayashi, M. Shibayama, Y. Kurotaki, M. Imanishi, T. Fujimori, N. Itoh, and S. Takada FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis Genes & Dev., April 1, 2002; 16(7): 870 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yousfi, F. Lasmoles, V. El Ghouzzi, and P. J. Marie Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNF{alpha} expression and caspase-2 activation Hum. Mol. Genet., February 1, 2002; 11(4): 359 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rozenblatt-Rosen, E. Mosonego-Ornan, E. Sadot, L. Madar-Shapiro, Y. Sheinin, D. Ginsberg, and A. Yayon Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations J. Cell Sci., January 2, 2002; 115(3): 553 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Funato, K. Ohtani, K. Ohyama, T. Kuroda, and M. Nakamura Common Regulation of Growth Arrest and Differentiation of Osteoblasts by Helix-Loop-Helix Factors Mol. Cell. Biol., November 1, 2001; 21(21): 7416 - 7428. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Thesleff, S. Keranen, and J. Jernvall Enamel Knots as Signaling Centers Linking Tooth Morphogenesis and Odontoblast Differentiation Advances in Dental Research, August 1, 2001; 15(1): 14 - 18. [Abstract] [PDF] |
||||
![]() |
M. K. Hajihosseini, S. Wilson, L. De Moerlooze, and C. Dickson A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes PNAS, March 27, 2001; 98(7): 3855 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome PNAS, December 19, 2000; 97(26): 14536 - 14541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mansukhani, P. Bellosta, M. Sahni, and C. Basilico Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)-Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts J. Cell Biol., June 12, 2000; 149(6): 1297 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Vartiainen, T. Mustonen, P. K. Mattila, P. J. Ojala, I. Thesleff, J. Partanen, and P. Lappalainen The Three Mouse Actin-depolymerizing Factor/Cofilins Evolved to Fulfill Cell-Type-specific Requirements for Actin Dynamics Mol. Biol. Cell, January 1, 2002; 13(1): 183 - 194. [Abstract] [Full Text] [PDF] |
||||